The New York Stock Exchange (NYSE) and the Nasdaq will participate in the national day of mourning for the late President ...
Channel's NaV1.7 inhibitors offer a promising ... and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...
Channel Therapeutics Corporation, a clinical-stage biotechnology company focused on non-opioid pain treatments, expressed encouragement regarding Vertex Pharmaceuticals' recent Phase 2 data for ...
The S&P 500 and the Nasdaq-100 indexes get new members added and old ones kicked out on Friday in a quarterly rebalancing ...
Shares of Palantir Technologies, MicroStrategy, and Axon Enterprise traded lower in their first day on the Nasdaq 100 index.